News & Analysis on Chocolate, Candy and Cocoa
Protective packaging demand in the US will grow 5.2 per cent annually through 2008, according to research analyst Freedonia Group. Gains will be driven by accelerating Internet and mail order catalogue sales and specialised packaging requirements.
A new study conducted by the FDA says that acrylamide found in fried and baked goods is unlikely to cause reproduction problems if the general public consume it as part of the average daily diet - but research is ongoing for its carcinogenic properties.
US Agro-food giant Cargill has confirmed that a $24 million class-action lawsuit accusing the US food giant of price-fixing will be settled following federal court approval. The end is now in sight for a law suit that dates back nine years.
At the beginning of the year Israel-based soy proteins specialist Solbar, announced its move into the soy proteins in China. Simon Pitman spoke to the company about the project and discovered that soy protein demand is a major driving force behind the...
Cadbury Schweppes has said that it is cautiously optimistic about the coming financial year, having today trading updates ahead of its interim and preliminary results. The company said that its US division had particularly shown a strong recovery,...
A research analyst claims that no RFID service provider can be considered low risk' due to the general lack of experience in this early stage of development of the technology - plant operators beware.
Changes to laws governing waste, energy consumption and emissions are forcing plants to alter their methods of operation. Anthony Fletcher spoke to the UK Environment Agency's head of waste management to find out what plant managers need to do to meet...
The European Commission has given the nod to Sygenta's Bt11 genetically modified sweetcorn, granting authorisation for it to be sold within the European Union over the next ten years. Although the Commission says that the sweetcorn should be clearly...
Netherlands-based Pharming has increased its stake in Australian company ProBio and is now hoping to accelerate the commercialisation of recombinant human lactoferrin in Asia, writes Phil Taylor.